These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 17684491)

  • 21. Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells.
    Sokol JP; Schiemann WP
    Mol Cancer Res; 2004 Mar; 2(3):183-95. PubMed ID: 15037657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
    Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
    Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion.
    Kondraganti S; Mohanam S; Chintala SK; Kin Y; Jasti SL; Nirmala C; Lakka SS; Adachi Y; Kyritsis AP; Ali-Osman F; Sawaya R; Fuller GN; Rao JS
    Cancer Res; 2000 Dec; 60(24):6851-5. PubMed ID: 11156378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-4, interleukin-10, and interleukin-1-receptor antagonist but not transforming growth factor-beta induce ramification and reduce adhesion molecule expression of rat microglial cells.
    Wirjatijasa F; Dehghani F; Blaheta RA; Korf HW; Hailer NP
    J Neurosci Res; 2002 Jun; 68(5):579-87. PubMed ID: 12111847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Nma on growth inhibition by TGF-betaa in human gastric carcinoma cell lines.
    Sasaki T; Sasahira T; Shimura H; Ikeda S; Kuniyasu H
    Oncol Rep; 2004 Jun; 11(6):1219-23. PubMed ID: 15138559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3).
    Chen A; Davis BH; Sitrin MD; Brasitus TA; Bissonnette M
    Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G864-74. PubMed ID: 12223346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.
    Bandyopadhyay A; Zhu Y; Cibull ML; Bao L; Chen C; Sun L
    Cancer Res; 1999 Oct; 59(19):5041-6. PubMed ID: 10519421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short hairpin RNA modulates transforming growth factor beta signaling in life-threatening liver failure in mice.
    Mizuguchi Y; Yokomuro S; Mishima T; Arima Y; Shimizu T; Kawahigashi Y; Kanda T; Yoshida H; Takizawa T; Tajiri T
    Gastroenterology; 2005 Nov; 129(5):1654-62. PubMed ID: 16285963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decorin gene transfer-mediated suppression of TGF-beta synthesis abrogates experimental malignant glioma growth in vivo.
    Ständer M; Naumann U; Dumitrescu L; Heneka M; Löschmann P; Gulbins E; Dichgans J; Weller M
    Gene Ther; 1998 Sep; 5(9):1187-94. PubMed ID: 9930319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.
    Zhou Y; Bian X; Le Y; Gong W; Hu J; Zhang X; Wang L; Iribarren P; Salcedo R; Howard OM; Farrar W; Wang JM
    J Natl Cancer Inst; 2005 Jun; 97(11):823-35. PubMed ID: 15928303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
    Medicherla S; Li L; Ma JY; Kapoun AM; Gaspar NJ; Liu YW; Mangadu R; O'Young G; Protter AA; Schreiner GF; Wong DH; Higgins LS
    Anticancer Res; 2007; 27(6B):4149-57. PubMed ID: 18229422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
    Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
    Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.
    Turley RS; Finger EC; Hempel N; How T; Fields TA; Blobe GC
    Cancer Res; 2007 Feb; 67(3):1090-8. PubMed ID: 17283142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion.
    Konduri SD; Rao CN; Chandrasekar N; Tasiou A; Mohanam S; Kin Y; Lakka SS; Dinh D; Olivero WC; Gujrati M; Foster DC; Kisiel W; Rao JS
    Oncogene; 2001 Oct; 20(47):6938-45. PubMed ID: 11687973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
    Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
    Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BCL-2-induced glioma cell invasiveness depends on furin-like proteases.
    Wick W; Wild-Bode C; Frank B; Weller M
    J Neurochem; 2004 Dec; 91(6):1275-83. PubMed ID: 15584904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
    Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
    Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.